Dear participants,
Welcome to the 8th International Cancer Immunotherapy and Immunomonitoring Conference!
This meeting is jointly organized by the International and Local Organizing Committees, and we have worked together to make this conference as informative and enjoyable as possible for you. We are looking forward to many superb presentations and discussions over the next few days that will allow you to consider new hypotheses and findings, present your own data and thoughts, and establish new collaborations and friendships. In addition to the outstanding basic and clinical science that will be presented, we hope that magnificent setting of the Hotel International close to the center of beautiful Bucharest will contribute to making this a very delightful and inspiring conference.
During this meeting, we will discuss cellular and molecular mechanisms of immune regulation in the tumor microenvironment that direct initiating and effector phases of antitumor immunity, as well control the efficacy and usefulness of anticancer immunotherapeutic modalities. We will also focus on recent clinical trial results and discuss the lessons we learned from preclinical evaluation of novel therapeutic approaches and immunomonitoring of patients with cancer receiving different modes of therapy. The special emphasis will be placed on topics presenting new ideas on how to improve the efficacy of cancer treatment, including combined chemo-radiation-immunotherapy, immunomodulators, and new targets for therapy. Invited plenary speakers and speakers selected from submitted abstracts, as well as session chairs will provide a framework for discussion. This will offer participants a unique opportunity to evaluate the field of tumor immunology and immunotherapy from different perspectives and might recommend new ways of solving existing problems and difficulties.
We hope that we have assembled one of the preeminent conferences on CITIM topics and we anticipate that the plenary sessions, short talks, poster presentations and after-the-meeting discussions will stimulate a breakthrough in our understanding of how to improve the efficiency of immunotherapy for cancer. If we can be of any assistance, please do not hesitate to call upon us. Please enjoy the meeting!
Sincerely,
CITIM-2025 Organizers
DOI: https://doi.org/10.3889/seejim.2025.8.CITIM
Published: 2025-03-17